Hyaluronic acid-coated ZIF-8 for the treatment of pneumonia caused by methicillin-resistant Staphylococcus aureus

Int J Biol Macromol. 2020 Jul 15:155:103-109. doi: 10.1016/j.ijbiomac.2020.03.187. Epub 2020 Mar 26.

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common causes of hospital infection. Here, we showed that hyaluronic acid modified organic metal framework material ZIF-8 could be a Trojan horse of vancomycin (Van) for effective treatment of MRSA infections. The Van-loaded nanoparticles were readily up-taken by macrophages via a CD44-mediated process and collapsed in the acidic condition of endosome/lysosome, as a consequence, it could eradicate MRSA with high efficiency in macrophages. This drug delivery system with negligible toxicity could resolve MRSA infections in a well-established mouse pneumonia model.

Keywords: Drug-resistant; Hyaluronic acid; Pneumonia; ZIF-8.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Drug Carriers / chemistry*
  • Female
  • Hyaluronic Acid / chemistry*
  • Methicillin-Resistant Staphylococcus aureus / drug effects*
  • Mice
  • Nanoparticles / chemistry*
  • Pneumonia, Staphylococcal / drug therapy*
  • RAW 264.7 Cells
  • Vancomycin / pharmacology
  • Zeolites / chemistry*

Substances

  • Anti-Bacterial Agents
  • Drug Carriers
  • Zeolites
  • Vancomycin
  • Hyaluronic Acid